Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats

Diabetic nephropathy is a major cause of end-stage renal disease (ESRD) in the general population. It is estimated that diabetic nephropathy will eventually develop in about 40% of all patients with diabetes; therefore, prevention is critical for delaying the development and progression of diabetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Ravi Prakash, Singh, Ansima, Jain, Arun K, Srinivasan, Bhartu Parsharthi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Department of Journal of Biomedical Research 2011
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596720/
https://www.ncbi.nlm.nih.gov/pubmed/23554718
http://dx.doi.org/10.1016/S1674-8301(11)60054-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596720/
https://www.ncbi.nlm.nih.gov/pubmed/23554718
http://dx.doi.org/10.1016/S1674-8301(11)60054-7

Ejemplares similares